SCHEMBL15466552

SCHEMBL15466552

CS(=O)(=O)Cc1nc(N)nc(-c2ccccc2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.56
ADORA1 P30542 4/20 0.56
POLB P06746 2/20 0.56
ADORA3 P0DMS8 2/20 0.56
ADORA2B P29275 2/20 0.56
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
NPSR1 Q6W5P4 1/20 0.45
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HRH4 Q9H3N8 1/20 0.43
MTOR P42345 1/20 0.43
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3686148 0.80 ADORA2A (0.64) ADORA2AADORA1POLBADORA3ADORA2B
Benzoguanamine SCHEMBL8930589 0.75 ADORA2A (0.76) ADORA2AADORA1POLBADORA3ADORA2B
SCHEMBL3952334 0.75 CYP1A2 (0.61) ADORA2AADORA1POLBADORA3ADORA2B
SCHEMBL821361 0.74 ADORA1 (0.56) ADORA2AADORA1POLBADORA3ADORA2B
SCHEMBL3424387 0.74 ADORA2A (0.90) ADORA2AADORA1POLBADORA3ADORA2B
Benzoguanamine SCHEMBL27898 0.74 ADORA2A (1.00) ADORA2AADORA1POLBADORA3ADORA2B
Benzoguanamine SCHEMBL28634836 0.74 ADORA2A (1.00) ADORA2AADORA1POLBADORA3ADORA2B
Benzoguanamine SCHEMBL917182 0.74 ADORA2A (1.00) ADORA2AADORA1POLBADORA3ADORA2B
Benzoguanamine SCHEMBL110169 0.73 ADORA2A (0.86) ADORA2AADORA1POLBADORA3ADORA2B
Benzoguanamine SCHEMBL2101162 0.73 ADORA2A (0.86) ADORA2AADORA1POLBADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8916557-B2 Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-12-23 US disclosed
US-20140045852-A1 SUBSTITUTED 4-ARYL-N-PHENYL-1,3,5-TRIAZIN-2-AMINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045852-A1 SUBSTITUTED 4-ARYL-N-PHENYL-1,3,5-TRIAZIN-2-AMINES PAH, NAT1, H1-5 ADORA2A 1110/4885ADORA1 1190/4885POLB 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.